Harbor Capital Advisors’s Freeline Therapeutics Holdings plc American Depositary Shares FRLN Stock Holding History

Harbor Capital Advisors’s Portfolio FRLN Stock Details FRLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell
2023 Q4	$129K	Buy
2023 Q3	$53K	Buy
2023 Q2	$27.6K	Buy
2023 Q1	$49.6K	Sell
2022 Q4	$64.3K	Sell
2022 Q3	$92K	Sell
2022 Q2	$129K	Buy
2022 Q1	$162K	Sell
2021 Q4	$360K	Buy